Scribe Therapeutics Inc. (SCTX) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 6Aug 11Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

—

Market Cap

$542.77M

MomentumView details →

1D Return

−6.95%

YTD Return

—

RSI (14)

59.2

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

—

Market Cap

$542.77M

RSI (14)

59.2

MomentumView details →

1D Return

−6.95%

YTD Return

—

ProfitabilityView details →

Gross Margin

—

Net Margin

—

EBITDA Margin

—

ROE (TTM)

—

ROA (TTM)

—

Asset Turnover

—

GrowthView details →

Revenue YoY

—

EPS YoY

—

FCF YoY

—

Revenue CAGR 3Y

—

EPS CAGR 3Y

—

EBITDA YoY

—

EarningsView details →

EPS (Actual)

−$2.62

EPS Surprise

27.62%

Beats (12Q)

1/12

Next Q EPS Est

—

Avg Surprise (4Q)

27.62%

Rev Surprise

−38.63%

Capital & dividendView details →

Debt/Equity

—

Current Ratio

—

Quick Ratio

—

Div Yield

—

Div Rate

—

Div Growth 1Y

—

Financials snapshotView financials →

Revenue (TTM)

—

Net Income (TTM)

—

Op. CF (TTM)

—

Latest newsMore news →

No recent news for SCTX.

Similar companies

Capricor Therapeutics, Inc.CAPR Ovid Therapeutics Inc.OVID Artiva Biotherapeutics, Inc.ARTV Eupraxia Pharmaceuticals Inc.EPRX ARS Pharmaceuticals, Inc.SPRY Entera Bio Ltd.ENTX Find similar companies →

Latest newsMore news →

No recent news for SCTX.